This statistic shows the value of biosimilar drugs and reference biological drugs sold in pharmacies in France from 2011 to 2013, in million euros. That year, biosimilar drug sales amounted to almost 80 million euros.
Value of biosimilar drug sales and their referents in pharmacies in France from 2011 to 2013 (in million euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Revenue of most dispensed drugs at pharmacies in Denmark 2022
- Basic Statistic U.S. healthcare: factors influencing prescribing decisions 2013
- Basic Statistic Medco Health Solutions' total net revenues 2006-2011
- Basic Statistic Number of parapharmacies in Italy 2007-2022
- Premium Statistic U.S. prescription market: market share of pharmacy benefit managers 2022
- Basic Statistic McKesson's total assets 2007-2023
- Basic Statistic Pharmacy revenue share in Sweden 2023, by type of product
- Premium Statistic Leading conventional pharmacies in Russia 2022, by market share
- Basic Statistic Pharmacy market revenue in Germany by sub-category 2022
- Basic Statistic Pharmacy market revenue in Germany 2010-2022
About the region
10
- Premium Statistic Global revenue of the Ipsen group 2014-2019
- Premium Statistic Global revenue in specialty medicine of the Ipsen group 2014-2019
- Premium Statistic Global revenue in general medicine of the Ipsen group 2014-2019
- Premium Statistic Boiron laboratories turnover in 2022, by region
- Premium Statistic Boiron laboratories turnover in France 2022, by region
- Premium Statistic Global revenue of the Ipsen group 2019, by geographical area
- Premium Statistic Net profit of Boiron laboratories 2013-2022, per share
- Premium Statistic Net investments of Boiron laboratories 2014-2022
- Premium Statistic Gross revenue of online poker in France 2011-2021
- Premium Statistic Technical products: turnover of the company Fnac Darty by country 2022
Selected statistics
1
Other regions
10
- Premium Statistic Turnover of Boiron laboratories abroad 2012-2022
- Basic Statistic Maine's medical cannabis spending 2018-2024
- Premium Statistic Boiron laboratories' European turnover in 2022, by country
- Premium Statistic Average number of prescriptions filled by Canadians 2018, by age
- Basic Statistic Vermont's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Oregon's medical cannabis sales value U.S. 2018-2024
- Premium Statistic Massachusetts' medical cannabis spending 2018-2024
- Basic Statistic Illinois' medical cannabis sales value U.S. 2018-2024
- Premium Statistic Colorado's medical cannabis spending 2018-2024
- Basic Statistic Prescription medicines: U.S. spending growth 2000-2022
Related statistics
10
- Premium Statistic Turnover of Boiron laboratories in North America 2022, by country
- Premium Statistic Turnover of the nonproprietary drugs segment of Boiron in 2022, by region
- Premium Statistic Global turnover of Boiron's specialties segment 2022, by region
- Premium Statistic Global turnover of Boiron laboratories 2012-2022
- Premium Statistic After-tax turnover of Boiron laboratories 2012-2019
- Premium Statistic Share capital of Boiron laboratories 2012-2022
- Premium Statistic Value of the liabilities of Boiron laboratories, by type in 2022
- Premium Statistic Dividend of Boiron laboratories 2013-2022, per share
- Premium Statistic EBITDA of Boiron laboratories 2012-2022
- Premium Statistic Income after tax, profit-sharing, amortizations and reserves of Boiron 2022
Further related statistics
10
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Merck & Co total assets 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Fragrance market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2022, by product type
- Toiletry market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2009-2022
- Ethical personal products: spending in the United Kingdom (UK) 2011-2021
Further Content: You might find this interesting as well
Statistics
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Merck & Co total assets 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Fragrance market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2022, by product type
- Toiletry market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2009-2022
- Ethical personal products: spending in the United Kingdom (UK) 2011-2021
Fédération nationale de la mutualité française. (October 13, 2014). Value of biosimilar drug sales and their referents in pharmacies in France from 2011 to 2013 (in million euros) [Graph]. In Statista. Retrieved April 19, 2024, from https://www.statista.com/statistics/785836/biosimilars-sales-value-france/
Fédération nationale de la mutualité française. "Value of biosimilar drug sales and their referents in pharmacies in France from 2011 to 2013 (in million euros)." Chart. October 13, 2014. Statista. Accessed April 19, 2024. https://www.statista.com/statistics/785836/biosimilars-sales-value-france/
Fédération nationale de la mutualité française. (2014). Value of biosimilar drug sales and their referents in pharmacies in France from 2011 to 2013 (in million euros). Statista. Statista Inc.. Accessed: April 19, 2024. https://www.statista.com/statistics/785836/biosimilars-sales-value-france/
Fédération nationale de la mutualité française. "Value of Biosimilar Drug Sales and Their Referents in Pharmacies in France from 2011 to 2013 (in Million Euros)." Statista, Statista Inc., 13 Oct 2014, https://www.statista.com/statistics/785836/biosimilars-sales-value-france/
Fédération nationale de la mutualité française, Value of biosimilar drug sales and their referents in pharmacies in France from 2011 to 2013 (in million euros) Statista, https://www.statista.com/statistics/785836/biosimilars-sales-value-france/ (last visited April 19, 2024)
Value of biosimilar drug sales and their referents in pharmacies in France from 2011 to 2013 (in million euros) [Graph], Fédération nationale de la mutualité française, October 13, 2014. [Online]. Available: https://www.statista.com/statistics/785836/biosimilars-sales-value-france/